NCT05818683 2026-02-13A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate CancerJanssen Research & Development, LLCPhase 1 Recruiting277 enrolled